Xiaobin Bai
Impact in
- Genetics top 10%
- Glioma Diagnosis and Treatment
- Biochemistry top 10%
- Sulfur Compounds in Biology
Papers in
- Genetics 16
- Glioma Diagnosis and Treatment 16
-
- Cancer, Hypoxia, and Metabolism 2
- Cancer-related molecular mechanisms research 1
- Co-authors
- Maode Wang (13 shared papers)Wanfu Xie (16 shared papers)Jia Wang (7 shared papers)Jianyang Xiang (8 shared papers)Wei Wu (8 shared papers)Gaofeng Xu (7 shared papers)Hao Liu (1 shared paper)Yong‐Xiao Cao (1 shared paper)
- Journals
- Journal of Pharmacy and Pharmacology (1 paper)Translational Oncology (1 paper)Journal of Cellular and Molecular Medicine (1 paper)Tumor Biology (1 paper)Journal of Molecular Neuroscience (1 paper)
- Partner nations
- China
In The Last Decade
Xiaobin Bai
23 papers receiving 440 citations
Peers
Comparison fields: 5 of 53
- Genetics 124
- Biochemistry 49
- Cancer Research 88
- Oncology 48
- Cell Biology 24
Countries citing papers authored by Xiaobin Bai
This map shows the geographic impact of Xiaobin Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Bai more than expected).
Fields of papers citing papers by Xiaobin Bai
This network shows the impact of papers produced by Xiaobin Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Bai. The network helps show where Xiaobin Bai may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobin Bai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 57 | |
| 2 | 2020 | 53 | |
| 3 | 2017 | 34 | |
| 4 | 2020 | 34 | |
| 5 | 2017 | 31 | |
| 6 | 2021 | 29 | |
| 7 | 2018 | 28 | |
| 8 | 2020 | 26 | |
| 9 | 2016 | 25 | |
| 10 | 2019 | 24 | |
| 11 | 2022 | 24 | |
| 12 | 2011 | 15 | |
| 13 | 2017 | 13 | |
| 14 | 2013 | 11 | |
| 15 | 2014 | 9 | |
| 16 | 2021 | 9 | |
| 17 | 2022 | 9 | |
| 18 | [Characterization of glycolytic phenotype of SHG44 human glioma cells under hypoxic conditions and its association with cell proliferation and apoptosis]. | 2013 | 4 |
| 19 | 2024 | 4 | |
| 20 | 2022 | 3 |
About Xiaobin Bai
Xiaobin Bai is a scholar working on Genetics, Cancer Research, Biochemistry, Neurology and Psychiatry and Mental health, having authored 24 papers that have together received 446 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (16 papers), Cancer, Hypoxia, and Metabolism (2 papers), Epilepsy research and treatment (1 paper), Cancer-related molecular mechanisms research (1 paper), Sulfur Compounds in Biology (1 paper), FOXO transcription factor regulation (1 paper), Inflammatory Biomarkers in Disease Prognosis (1 paper) and Circular RNAs in diseases (1 paper). The work is most often cited by research in Genetics (124 citations), Biochemistry (49 citations), Cancer Research (88 citations), Oncology (48 citations) and Cell Biology (24 citations). Xiaobin Bai has collaborated with scholars based in China. Frequent co-authors include Maode Wang, Wanfu Xie, Jia Wang, Jianyang Xiang, Wei Wu, Gaofeng Xu, Hao Liu, Yong‐Xiao Cao, Alafate Wahafu and Yafei Wang. Their work appears in journals such as Journal of Pharmacy and Pharmacology, Translational Oncology, Journal of Cellular and Molecular Medicine, Tumor Biology and Journal of Molecular Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.